Cargando…

GATA1-defective immune-megakaryocytes as possible drivers of idiopathic pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disorder with limited therapeutic options. Insufficient understanding of driver mutations and poor fidelity of currently available animal models has limited the development of effective therapies. Since GATA1 deficient megakaryocytes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gobbo, Francesca, Zingariello, Maria, Verachi, Paola, Falchi, Mario, Arciprete, Francesca, Martelli, Fabrizio, Peli, Angelo, Mazzarini, Maria, Vierstra, Jeff, Mead-Harvey, Carolyn, Dueck, Amylou C., Sarli, Giuseppe, Nava, Stefano, Sgalla, Giacomo, Richeldi, Luca, Migliaccio, Anna Rita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10327123/ https://www.ncbi.nlm.nih.gov/pubmed/37425686 http://dx.doi.org/10.1101/2023.06.20.542249

Ejemplares similares

hGATA1 Under the Control of a μLCR/β-Globin Promoter Rescues the Erythroid but Not the Megakaryocytic Phenotype Induced by the Gata1 ( low ) Mutation in Mice
por: Martelli, Fabrizio, et al.
Publicado: (2021)

Resident Self-Tissue of Proinflammatory Cytokines Rather Than Their Systemic Levels Correlates with Development of Myelofibrosis in Gata1(low) Mice
por: Zingariello, Maria, et al.
Publicado: (2022)

Single cell analysis of the localization of the hematopoietic stem cells within the bone marrow architecture identifies niche-specific proliferation dynamics
por: Mazzarini, Maria, et al.
Publicado: (2023)

Role of β1 integrin in thrombocytopoiesis
por: Mazzarini, Maria, et al.
Publicado: (2021)

Shared and Distinctive Ultrastructural Abnormalities Expressed by Megakaryocytes in Bone Marrow and Spleen From Patients With Myelofibrosis
por: Zingariello, Maria, et al.
Publicado: (2020)

The CXCR1/CXCR2 Inhibitor Reparixin Alters the Development of Myelofibrosis in the Gata1 (low) Mice
por: Verachi, Paola, et al.
Publicado: (2022)

Megakaryocyte Contribution to Bone Marrow Fibrosis: many Arrows in the Quiver
por: Malara, Alessandro, et al.
Publicado: (2018)

A Novel Megakaryocyte Subpopulation Poised to Exert the Function of HSC Niche as Possible Driver of Myelofibrosis
por: Migliaccio, Anna Rita
Publicado: (2021)

Oncogenic Gata1 causes stage-specific megakaryocyte differentiation delay
por: Juban, Gaëtan, et al.
Publicado: (2020)

Overexpression of GATA1 Confers Resistance to Chemotherapy in Acute Megakaryocytic Leukemia
por: Caldwell, John Timothy, et al.
Publicado: (2013)

The thrombopoietin/MPL axis is activated in the Gata1(low) mouse model of myelofibrosis and is associated with a defective RPS14 signature
por: Zingariello, M, et al.
Publicado: (2017)

Repercussion of Megakaryocyte-Specific Gata1 Loss on Megakaryopoiesis and the Hematopoietic Precursor Compartment
por: Meinders, Marjolein, et al.
Publicado: (2016)

Editorial: Megakaryocytes as regulators of tumor microenvironments
por: Migliaccio, Anna Rita, et al.
Publicado: (2022)

FOG-1 and GATA-1 act sequentially to specify definitive megakaryocytic and erythroid progenitors
por: Mancini, Elena, et al.
Publicado: (2012)

Pharmacological treatment of idiopathic pulmonary fibrosis: time to step out of the comfort zone?
por: Sgalla, Giacomo, et al.
Publicado: (2020)

Reply to Huang and Wei, Kang et al., and Ehteshami-Afshar and Raj
por: Sgalla, Giacomo, et al.
Publicado: (2022)

Better to Be an Agnostic than a Believer (at Least in Pulmonary Fibrosis)
por: Sgalla, Giacomo, et al.
Publicado: (2022)

A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis
por: Mascarenhas, John, et al.
Publicado: (2023)

A Unique Role of GATA1s in Down Syndrome Acute Megakaryocytic Leukemia Biology and Therapy
por: Xavier, Ana C., et al.
Publicado: (2011)

The Shorter, the Better: Can We Improve Efficiency of Idiopathic Pulmonary Fibrosis Trials?
por: Sgalla, Giacomo, et al.
Publicado: (2022)

PSTPIP2 dysregulation contributes to aberrant terminal differentiation in GATA-1-deficient megakaryocytes by activating LYN
por: Liu, L, et al.
Publicado: (2014)

GATA-1 as a Regulator of Mast Cell Differentiation Revealed by the Phenotype of the GATA-1(low) Mouse Mutant
por: Migliaccio, Anna Rita, et al.
Publicado: (2003)

Home spirometry to assess efficacy of pirfenidone in progressive unclassifiable interstitial lung disease: better the devil you know than the devil you don’t
por: Sgalla, Giacomo, et al.
Publicado: (2020)

Phosphoproteomic Landscaping Identifies Non-canonical cKIT Signaling in Polycythemia Vera Erythroid Progenitors
por: Federici, Giulia, et al.
Publicado: (2019)

The leukemia associated ETO nuclear repressor gene is regulated by the GATA-1 transcription factor in erythroid/megakaryocytic cells
por: Ajore, Ram, et al.
Publicado: (2010)

Stepwise GATA1 and SMC3 mutations alter megakaryocyte differentiation in a Down syndrome leukemia model
por: Arkoun, Brahim, et al.
Publicado: (2022)

P1002: PROTEOMIC SCREENING IDENTIFIES MEGAKARYOCYTE DERIVED PF4/CXCL4 AS A CRITICAL DRIVER OF MYELOFIBROSIS
por: Malara, Alessandro, et al.
Publicado: (2023)

Occurrence of idiopathic pulmonary fibrosis during immunosuppressive treatment: a case report
por: Cerri, Stefania, et al.
Publicado: (2016)

Down syndrome-related transient abnormal myelopoiesis is attributed to a specific erythro-megakaryocytic subpopulation with GATA1 mutation
por: Nishinaka-Arai, Yoko, et al.
Publicado: (2020)

Single-cell profiling of human megakaryocyte-erythroid progenitors identifies distinct megakaryocyte and erythroid differentiation pathways
por: Psaila, Bethan, et al.
Publicado: (2016)

TGF-β1 protein trap AVID200 beneficially affects hematopoiesis and bone marrow fibrosis in myelofibrosis
por: Varricchio, Lilian, et al.
Publicado: (2021)

Patients with hypercortisolemic Cushing disease possess a distinct class of hematopoietic progenitor cells leading to erythrocytosis
por: Varricchio, Lilian, et al.
Publicado: (2022)

Population‐level evidence of survival benefits of patient‐reported outcome symptom monitoring software systems in routine cancer care
por: Basch, Ethan, et al.
Publicado: (2020)

COVID-19 Vaccine in Patients with Exacerbation of Idiopathic Pulmonary Fibrosis
por: Sgalla, Giacomo, et al.
Publicado: (2022)

Human megakaryocytes. V. Changes in the phenotypic profile of differentiating megakaryocytes
Publicado: (1985)

Hungry megakaryocytes on the hunt? An unusual case of extensive megakaryocyte emperipolesis
por: Vijaya Devi, S., et al.
Publicado: (2021)

Genome-wide Analysis of Simultaneous GATA1/2, RUNX1, FLI1, and SCL Binding in Megakaryocytes Identifies Hematopoietic Regulators
por: Tijssen, Marloes R., et al.
Publicado: (2011)

CBFβ-MYH11 interferes with megakaryocyte differentiation via modulating a gene program that includes GATA2 and KLF1
por: Yi, Guoqiang, et al.
Publicado: (2019)

Human megakaryocytes. II. Expression of platelet proteins in early marrow megakaryocytes
Publicado: (1981)

Novel strategies for the treatment of myelofibrosis driven by recent advances in understanding the role of the microenvironment in its etiology
por: Eran, Zimran, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_l8vkov7l0i84t3jmbmu5f72hv2